Serum Institute of India

	SII's free supply of Covishield to Centre: First lot of 80 lakh doses set for dispatch Since the launch of the anti-Covid vaccination drive, SII has so far provided 170 crore doses of Covishield to the government. published on : 14th January 2023
	COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla Covovax works very well against omicron variant,more than Covishield, says Adar Poonawalla. published on : 9th January 2023
	Posing as Adar Poonawalla, scammers dupe SII of Rs 1 cr; 7 nabbed A complaint in this regard was registered and during the investigation, police zeroed in on the eight accounts to which the money was transferred. published on : 26th November 2022
	SII stopped Covishield production in Dec 2021; Poonawalla; claims are no takers for booster shots The SII had announced its partnership with Oxford University to manufacture the vaccine in April 2020. published on : 20th October 2022
	Fraudsters dupe Serum Institute of Rs 1 crore by asking for money transfer in CEO's name The fraud unfolded between the afternoons of Wednesday and Thursday, said an official of Bundgarden police station. published on : 10th September 2022
	Bombay HC issues notice to Central govt, Serum Institute over plea on alleged Covid vaccine death Dilip Lunawat in his petition blamed the authorities for creating alleged false narratives and misrepresentations about the Coronavirus vaccine. published on : 3rd September 2022
	India's first vaccine against cervical cancer to launch on September 1 The most awaited vaccine will be launched by the Union Minister of State (Independent Charge) Science & Technology Jitendra Singh on September 1. published on : 31st August 2022
	Odisha to introduce HPV vax in 10 aspirational districts in the first phase The State government has also decided to expand screening and services for breast and cervical cancers from medical colleges to the district headquarters hospital (DHH). published on : 15th August 2022
	Drug controller allows sale of Serum Institute’s cervical cancer vaccine The DCGI’s approval came following a recommendation by the Subject Expert Committee (SEC) on Covid-19 of the CDSCO on June 15. published on : 13th July 2022
	Panel for emergency use approval to SII vaccination for 7-11 age group Officials said the Subject Expert Committee deliberated upon the matter and recommended EUA for use in younger children. published on : 25th June 2022
	Government panel recommends market authorisation for SII's qHPV vaccine against cervical cancer In the application, Singh is learnt to have stated that qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times higher than the baseline. published on : 15th June 2022
	Serum Institute, Symbiosis to set up research centre for vaccine development The entity will work towards improving health equity against future pandemics and infectious diseases. It will also ensure cross-programme coordination and collaboration. published on : 13th May 2022
	Millions of COVID vaccines unsold; stopped production since December 2021: Adar Poonawalla He also called for speeding up the decision to vaccinate young kids and said if they can be given other immunisation vaccines why not for the COVID-19. published on : 22nd April 2022
	Poonawalla warns against return to business-as-usual approach Calling for increased adoption of booster doses, Poonawalla said it is also needed because people need to travel internally and outside, many countries have made booster doses mandatory for travel. published on : 22nd April 2022
	Panel seeks more data on Serum Institute's EUA application for Covovax use The SII had last month submitted an application to the Drugs Controller General of India (DCGI) seeking emergency use authorisation (EUA) for Covovax's use among children in the age group. published on : 12th April 2022
	Covishield & Covaxin prices cut, hospitals to pay Rs 225 per dose The precautionary dose has to be of the same vaccine used for the first two doses. published on : 10th April 2022
	Serum Institute, Bharat Biotech cut COVID vaccine prices for private hospitals to Rs 225 The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose. published on : 9th April 2022
	Serum Institute's Covishield precaution dose priced at Rs 600 per shot The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose. published on : 8th April 2022
	Low number of COVID-19 cases now as India chose right vaccine, says Poonawalla Speaking to reporters on the sidelines of the 'Alternate Fuel Conclave', he said the fourth wave, if at all it occurs, will hopefully be mild. published on : 4th April 2022
	SC reserves verdict on plea seeking data on clinical trials of vaccination drives A petition filed by a former member of the National Technical Advisory Group on Immunisation (NTAGI) Jacob Puliyel sought disclosure of post-vaccination data and clinical trial data. published on : 22nd March 2022